Skip to main content
Erschienen in: Infection 2/2016

27.10.2015 | Original Paper

HCV–HIV coinfected pregnant women: data from a multicentre study in Italy

verfasst von: S. Baroncelli, M. F. Pirillo, R. Amici, E. Tamburrini, O. Genovese, M. Ravizza, A. Maccabruni, G. Masuelli, G. Guaraldi, G. Liuzzi, C. Pinnetti, V. Giacomet, A. Degli Antoni, A. Vimercati, S. Dalzero, V. Sacchi, Marco Floridia

Erschienen in: Infection | Ausgabe 2/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To provide information about main pregnancy outcomes in HIV–HCV coinfected women and about the possible interactions between HIV and HCV in this particular population.

Methods

Data from a multicenter observational study of pregnant women with HIV, conducted in Italian University and Hospital Clinics between 2001 and 2015, were used. Eligibility criteria for analysis were HCV coinfection and at least one detectable plasma HCV-RNA viral load measured during pregnancy. Qualitative variables were compared using the Chi-square or the Fisher test and quantitative variables using the Mann–Whitney U test. The Spearman’s coefficient was used to evaluate correlations between quantitative variables.

Results

Among 105 women with positive HCV-RNA, median HCV viral load was substantially identical at the three trimesters (5.68, 5.45, and 5.86 log IU/ml, respectively), and 85.7 % of the women had at least one HCV-RNA value >5 log IU/ml. Rate of preterm delivery was 28.6 % with HCV-RNA <5 log IU/ml and 43.2 % with HCV-RNA >5log (p = 0.309). Compared to women with term delivery, women with preterm delivery had higher median HCV-RNA levels (third trimester: 6.00 vs. 5.62 log IU/ml, p = 0.037). Third trimester HIV-RNA levels were below 50 copies/ml in 47.7 % of the cases. No cases of vertical HIV transmission occurred. Rate of HCV transmission was 9.0 % and occurred only with HCV-RNA levels >5 log IU/ml.

Conclusions

Coinfection with HIV and HCV has relevant consequences in pregnancy: HIV coinfection is associated with high HCV-RNA levels that might favour HCV transmission, and HCV infection might further increase the risk of preterm delivery in women with HIV. HCV/HIV coinfected women should be considered a population at high risk of adverse outcomes.
Literatur
1.
Zurück zum Zitat Gibb DM, Goodall RL, Dunn DT, et al. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet. 2000;356:904–7.CrossRefPubMed Gibb DM, Goodall RL, Dunn DT, et al. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet. 2000;356:904–7.CrossRefPubMed
2.
Zurück zum Zitat Steininger C, Kundi M, Jatzko G, Kiss H, Lischka A, Holzmann H. Increased risk of mother-to-infant transmission of hepatitis C virus by intrapartum infantile exposure to maternal blood. J Infect Dis. 2003;187:345–51.CrossRefPubMed Steininger C, Kundi M, Jatzko G, Kiss H, Lischka A, Holzmann H. Increased risk of mother-to-infant transmission of hepatitis C virus by intrapartum infantile exposure to maternal blood. J Infect Dis. 2003;187:345–51.CrossRefPubMed
3.
Zurück zum Zitat Mok J, Pembrey L, Tovo PA, Newell ML. European Paediatric Hepatitis C Virus Network. When does mother to child transmission of hepatitis C virus occur? Arch Dis Child Fetal Neonatal. 2005;90:F156–60.CrossRef Mok J, Pembrey L, Tovo PA, Newell ML. European Paediatric Hepatitis C Virus Network. When does mother to child transmission of hepatitis C virus occur? Arch Dis Child Fetal Neonatal. 2005;90:F156–60.CrossRef
4.
Zurück zum Zitat Roberts EA, Yeung L. Maternal-infant transmission of hepatitis C virus infection. Hepatology. 2002;36:S106–13.CrossRefPubMed Roberts EA, Yeung L. Maternal-infant transmission of hepatitis C virus infection. Hepatology. 2002;36:S106–13.CrossRefPubMed
5.
Zurück zum Zitat European Paediatric Hepatitis. C Virus Network. A significant sex-but not elective cesarean section-effect on mother-to-child transmission ofhepatitis C virus infection. J Infect Dis. 2005;192:1872–9.CrossRef European Paediatric Hepatitis. C Virus Network. A significant sex-but not elective cesarean section-effect on mother-to-child transmission ofhepatitis C virus infection. J Infect Dis. 2005;192:1872–9.CrossRef
6.
Zurück zum Zitat Mast EE, Hwang LY, Seto DS, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCVinfection acquired in infancy. J Infect Dis. 2005;192:1880–9.CrossRefPubMed Mast EE, Hwang LY, Seto DS, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCVinfection acquired in infancy. J Infect Dis. 2005;192:1880–9.CrossRefPubMed
7.
8.
9.
Zurück zum Zitat Tosone G, Maraolo AE, Mascolo S, Palmiero G, Tambaro O, Orlando R. Vertical hepatitis C virus transmission: main questions and answers. World J Hepatol. 2014;6:538–48.PubMedPubMedCentral Tosone G, Maraolo AE, Mascolo S, Palmiero G, Tambaro O, Orlando R. Vertical hepatitis C virus transmission: main questions and answers. World J Hepatol. 2014;6:538–48.PubMedPubMedCentral
10.
Zurück zum Zitat Dunkelberg JC, Berkley EM, Thiel KW, Leslie KK. Hepatitis B and C in pregnancy: a review and recommendations for care. J Perinatol. 2014. doi:10.1038/jp.2014.167 (epub ahead of print).PubMed Dunkelberg JC, Berkley EM, Thiel KW, Leslie KK. Hepatitis B and C in pregnancy: a review and recommendations for care. J Perinatol. 2014. doi:10.​1038/​jp.​2014.​167 (epub ahead of print).PubMed
11.
Zurück zum Zitat Dal Molin G, D’Agaro P, Ansaldi F, et al. Mother-to-infant transmission of hepatitis C virus: rate of infection and assessment of viral load and IgM anti-HCV as risk factors. J Med Virol. 2002;67:137–42.CrossRefPubMed Dal Molin G, D’Agaro P, Ansaldi F, et al. Mother-to-infant transmission of hepatitis C virus: rate of infection and assessment of viral load and IgM anti-HCV as risk factors. J Med Virol. 2002;67:137–42.CrossRefPubMed
12.
Zurück zum Zitat Ruiz-Extremera A, Muñoz-Gámez JA, Salmerón-Ruiz MA, et al. Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children. Hepatology. 2011;53:1830–8.CrossRefPubMed Ruiz-Extremera A, Muñoz-Gámez JA, Salmerón-Ruiz MA, et al. Genetic variation in interleukin 28B with respect to vertical transmission of hepatitis C virus and spontaneous clearance in HCV-infected children. Hepatology. 2011;53:1830–8.CrossRefPubMed
13.
Zurück zum Zitat Polis CB, Shah SN, Johnson KE, Gupta A. Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: a meta-analysis. Clin Infect Dis. 2007;44:1123–31.CrossRefPubMed Polis CB, Shah SN, Johnson KE, Gupta A. Impact of maternal HIV coinfection on the vertical transmission of hepatitis C virus: a meta-analysis. Clin Infect Dis. 2007;44:1123–31.CrossRefPubMed
14.
Zurück zum Zitat Zanetti AR, Tanzi E, Paccagnini S, et al. Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCVTransmission. Lancet. 1995;345:289–91.CrossRefPubMed Zanetti AR, Tanzi E, Paccagnini S, et al. Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCVTransmission. Lancet. 1995;345:289–91.CrossRefPubMed
15.
Zurück zum Zitat Paccagnini S, Principi N, Massironi E, et al. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. Pediatr Infect Dis J. 1995;14:195–9.CrossRefPubMed Paccagnini S, Principi N, Massironi E, et al. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. Pediatr Infect Dis J. 1995;14:195–9.CrossRefPubMed
16.
Zurück zum Zitat Tovo PA, Palomba E, Ferraris G, et al. Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1. Italian Study Group for HCV Infection in Children. Clin Infect Dis. 1997;25:1121–4.CrossRefPubMed Tovo PA, Palomba E, Ferraris G, et al. Increased risk of maternal-infant hepatitis C virus transmission for women coinfected with human immunodeficiency virus type 1. Italian Study Group for HCV Infection in Children. Clin Infect Dis. 1997;25:1121–4.CrossRefPubMed
17.
Zurück zum Zitat Verucchi G, Calza L, Manfredi R, Chiodo F. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection. 2004;32:33–46.CrossRefPubMed Verucchi G, Calza L, Manfredi R, Chiodo F. Human immunodeficiency virus and hepatitis C virus coinfection: epidemiology, natural history, therapeutic options and clinical management. Infection. 2004;32:33–46.CrossRefPubMed
18.
Zurück zum Zitat Floridia M, Ravizza M, Tamburrini E, et al. Diagnosis of HIV infection in pregnancy: data from a national cohort of pregnant women with HIV in Italy. Epidemiol Infect. 2006;134:1120–7.CrossRefPubMedPubMedCentral Floridia M, Ravizza M, Tamburrini E, et al. Diagnosis of HIV infection in pregnancy: data from a national cohort of pregnant women with HIV in Italy. Epidemiol Infect. 2006;134:1120–7.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Girardi E, Vanacore P, Costa F, Solmone M, Angeletti C, Capobianchi MR, et al. Trends in HIV prevalence among pregnant women in Italy, 1994–2002. J Acquir Immune Defic Syndr. 2006;41:361–4.CrossRefPubMed Girardi E, Vanacore P, Costa F, Solmone M, Angeletti C, Capobianchi MR, et al. Trends in HIV prevalence among pregnant women in Italy, 1994–2002. J Acquir Immune Defic Syndr. 2006;41:361–4.CrossRefPubMed
20.
Zurück zum Zitat Scheuerle A, Tilson H. Birth defect classification by organ system: a novel approach to heighten teratogenic signalling in a pregnancy registry. Pharmacoepidemiol Drug Saf. 2002;11:465–75.CrossRefPubMed Scheuerle A, Tilson H. Birth defect classification by organ system: a novel approach to heighten teratogenic signalling in a pregnancy registry. Pharmacoepidemiol Drug Saf. 2002;11:465–75.CrossRefPubMed
21.
Zurück zum Zitat Bertino E, Spada E, Occhi L, et al. Neonatal anthropometric charts: the Italian neonatal study compared with other European studies. J Pediatr Gastroenterol Nutr. 2010;51:353–61.PubMed Bertino E, Spada E, Occhi L, et al. Neonatal anthropometric charts: the Italian neonatal study compared with other European studies. J Pediatr Gastroenterol Nutr. 2010;51:353–61.PubMed
22.
Zurück zum Zitat AIDS Clinical Trials Group (ACTG). Division of AIDS Table For Grading The Severity of Adult and Pediatric Adverse Events Version 1.0, Division of AIDS, National Institute of Allergy and Infectious Diseases. December 2004; Clarification August 2009. AIDS Clinical Trials Group (ACTG). Division of AIDS Table For Grading The Severity of Adult and Pediatric Adverse Events Version 1.0, Division of AIDS, National Institute of Allergy and Infectious Diseases. December 2004; Clarification August 2009.
23.
Zurück zum Zitat Snijdewind IJ, Smit C, Godfried MH, Nellen JF, de Wolf F, Boer K, van der Ende ME. HCV coinfection, an important risk factor for hepatotoxicity in pregnant women starting antiretroviral therapy. J Infect. 2012;64:409–16.CrossRefPubMed Snijdewind IJ, Smit C, Godfried MH, Nellen JF, de Wolf F, Boer K, van der Ende ME. HCV coinfection, an important risk factor for hepatotoxicity in pregnant women starting antiretroviral therapy. J Infect. 2012;64:409–16.CrossRefPubMed
24.
Zurück zum Zitat Pawlotsky JM. Use and interpretation of virological tests for hepatitis C. Hepatology. 2002;36:S65–73.CrossRefPubMed Pawlotsky JM. Use and interpretation of virological tests for hepatitis C. Hepatology. 2002;36:S65–73.CrossRefPubMed
25.
Zurück zum Zitat Floridia M, Tamburrini E, Anzidei G, Tibaldi C, Muggiasca ML, Guaraldi G, et al. Declining HCV seroprevalence in pregnant women with HIV. Epidemiol Infect. 2010;138:1317–21.CrossRefPubMed Floridia M, Tamburrini E, Anzidei G, Tibaldi C, Muggiasca ML, Guaraldi G, et al. Declining HCV seroprevalence in pregnant women with HIV. Epidemiol Infect. 2010;138:1317–21.CrossRefPubMed
26.
Zurück zum Zitat Basso M, Franzetti M, Scaggiante R, et al. HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV–HCV co-infected patients: a 3-years follow-up study. AIDS Res Ther. 2014;11:21.CrossRefPubMedPubMedCentral Basso M, Franzetti M, Scaggiante R, et al. HCV RNA viral load is independent from CD4 cell count and plasma HIV RNA viral load in immunocompetent HIV–HCV co-infected patients: a 3-years follow-up study. AIDS Res Ther. 2014;11:21.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Sibiude J, Warszawski J, Tubiana R, et al. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost? Clin Infect Dis. 2012;54:1348–60.CrossRefPubMed Sibiude J, Warszawski J, Tubiana R, et al. Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost? Clin Infect Dis. 2012;54:1348–60.CrossRefPubMed
29.
Zurück zum Zitat Short CE, Taylor GP. Antiretroviral therapy and preterm birth in HIV-infected women. Expert Rev Anti Infect Ther. 2014;12:293–306.CrossRefPubMed Short CE, Taylor GP. Antiretroviral therapy and preterm birth in HIV-infected women. Expert Rev Anti Infect Ther. 2014;12:293–306.CrossRefPubMed
30.
Zurück zum Zitat Ravizza M, Martinelli P, Bucceri A, et al. Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women. J Infect Dis. 2007;195:913–4.CrossRefPubMed Ravizza M, Martinelli P, Bucceri A, et al. Treatment with protease inhibitors and coinfection with hepatitis C virus are independent predictors of preterm delivery in HIV-infected pregnant women. J Infect Dis. 2007;195:913–4.CrossRefPubMed
31.
Zurück zum Zitat Safir A, Levy A, Sikuler E, Sheiner E. Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome. Liver Int. 2010;30:765–70.CrossRefPubMed Safir A, Levy A, Sikuler E, Sheiner E. Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome. Liver Int. 2010;30:765–70.CrossRefPubMed
32.
Zurück zum Zitat Connell LE, Salihu HM, Salemi JL, August EM, Weldeselasse H, Mbah AK. Maternal hepatitis B and hepatitis C carrier status and perinatal outcomes. Liver Int. 2011;31:1163–70.CrossRefPubMed Connell LE, Salihu HM, Salemi JL, August EM, Weldeselasse H, Mbah AK. Maternal hepatitis B and hepatitis C carrier status and perinatal outcomes. Liver Int. 2011;31:1163–70.CrossRefPubMed
Metadaten
Titel
HCV–HIV coinfected pregnant women: data from a multicentre study in Italy
verfasst von
S. Baroncelli
M. F. Pirillo
R. Amici
E. Tamburrini
O. Genovese
M. Ravizza
A. Maccabruni
G. Masuelli
G. Guaraldi
G. Liuzzi
C. Pinnetti
V. Giacomet
A. Degli Antoni
A. Vimercati
S. Dalzero
V. Sacchi
Marco Floridia
Publikationsdatum
27.10.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Infection / Ausgabe 2/2016
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-015-0852-0

Weitere Artikel der Ausgabe 2/2016

Infection 2/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.